Angiochem commences ANG1005 Phase 2 clinical study in HER2+ breast cancer patients wi - HER2 Support Group Forums

		HER2 Support Group Forums > General Cancer News
Angiochem commences ANG1005 Phase 2 clinical study in HER2+ breast cancer patients wi

General Cancer News Latest Breast Cancer News from Moreover Technologies

Prev

Previous Post

Next Post

Next

05-31-2014, 03:10 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,104	Angiochem commences ANG1005 Phase 2 clinical study in HER2+ breast cancer patients wi Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), today announced the initiation of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in HER2+ breast cancer patients. More...

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 11:40 AM.

free webpage hit counter